Moderna Stock Sinks To Over 5-Year Low On $1B Sales Guidance …

1 day ago · This sharp decline follows the company’s decision to lower its 2025 sales guidance by approximately $1 billion, citing a challenging outlook in the COVID-19 vaccine market. …

$1
OFF

Moderna Stock Sinks To Over 5-Year Low On $1B Sales Guidance …

2 weeks from now

1 day ago · This sharp decline follows the company’s decision to lower its 2025 sales guidance by approximately $1 billion, citing a challenging outlook in the COVID-19 vaccine market. …

stocktwits.com

17%
OFF

Moderna Stock Plunges Nearly 17% After Company Lowers 2025 …

2 weeks from now

Moderna lowered its 2025 sales guidance by roughly $1 billion, as it continues to cut costs. The biotech company now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, …

msn.com

$1
OFF

Moderna Shares Plunge After Predicting Steep 2025 Sales Decline

2 weeks from now

1 day ago · The company revised its 2025 revenue expectations to a range of $1.5 billion to $2.5 billion, falling far short of Wall Street's consensus of $2.92 billion, according to the financial …

newsweek.com

20%
OFF

Moderna's $1 Billion Revenue Forecast Cut Sends Stock …

2 weeks from now

1 day ago · Shares of Moderna dropped more than 20% intraday to $33.44, more than erasing gains last week after the first bird-flu death was reported in the U.S. The stock has lost about …

investopedia.com

25%
OFF

Moderna Earnings Beat Estimates. Why The Stock Is Sinking.

2 weeks from now

Moderna cut its full-year revenue guidance Thursday by as much as 25%, citing “very low” Covid-19 vaccine sales in Europe and tight competition in the U.S.

barrons.com

93%
OFF

Moderna Shares Drop To Five-Year Low After Slashing Revenue, …

2 weeks from now

1 day ago · The stock has tumbled 93% from its five-year high of $456.76 in August 2021. Moderna, which makes the Spikevax RNA-based Covid-19 vaccine, said before the bell it now …

marketwatch.com

$3
OFF

Who's To Blame As Moderna's Stock Falls Amid Slashed Guidance?

2 weeks from now

Aug 1, 2024 · The company said it now expects total sales between $3 billion and $3.5 billion for the year. That's down from the $4 billion forecast in the first quarter. The guidance came amid …

yahoo.com

$1
OFF

Moderna Stock Drops On Plans To Cut $1.1B In R&D Costs

2 weeks from now

Sep 12, 2024 · Moderna Expects FDA Approval of 10 New Products Over the Next 3 Years . Moderna said Thursday that based on current trial data, it expects to receive Food and Drug …

investopedia.com

20%
OFF

Moderna Stock Falls 20% In A Month: Time To Sell Or Hold?

2 weeks from now

Oct 16, 2024 · On Sept. 12, management issued fresh sales guidance for the full year 2025 and also revised the previously issued sales outlook for 2028. Moderna expects to generate …

yahoo.com

59%
OFF

StockWatch: Moderna's $1.1B R&D Cut, Profitability Delay Jolt …

2 weeks from now

Stock down 59% Since May 24. Moderna shares have nosedived 59% since May 24, when they closed at their 2024 high of $166.61, as investors reacted to lower-than-expected vaccine …

genengnews.com

4%
OFF

Moderna Crashes After Slashing Its R&D Budget, Sales Guidance

2 weeks from now

On today's stock market, Moderna stock plummeted 12.4% to 69.68. Shares are poised to open at a 10-month low. Moderna stock has dropped off markedly after shooting to a record high in …

msn.com

20%
OFF

Moderna Headed For Biggest One-day Decline On Record After …

2 weeks from now

Moderna Inc.’s stock tumbled 20% Thursday, after the biotech company cut its sales guidance for 2024, offsetting a narrower-than-expected second-quarter loss and revenue that topped …

marketwatch.com

20%
OFF

Moderna Stock Falls 20% In A Month: Time To Sell Or Hold?

2 weeks from now

Oct 16, 2024 · On Sept. 12, management issued fresh sales guidance for the full year 2025 and also revised the previously issued sales outlook for 2028. Moderna expects to generate …

nasdaq.com

20%
OFF

Moderna Stock Plunges Nearly 20% As Company Reports Poor …

2 weeks from now

Sep 12, 2024 · Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development (R&D) budget by about 20% over the next three years, a result of …

yahoo.com

$1
OFF

Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut

2 weeks from now

Sep 13, 2024 · Shares of Moderna fell Friday after taking on steep losses a day earlier on the news that it plans to cut research and development spending by $1.1 billion by 2027.

investopedia.com

96%
OFF

Moderna (MRNA) Stock Sinks As Market Gains: Here's Why

2 weeks from now

Oct 14, 2024 · The latest trading day saw Moderna (MRNA) settling at $57.73, representing a -0.96% change from its previous close.

yahoo.com

FAQs about Moderna Stock Sinks To Over 5-Year Low On $1B Sales Guidance … Coupon?

Why did Moderna stock drop 2024?

Moderna (MRNA) shares slid more than 20% Thursday after the company slashed its sales guidance for 2024, largely because of a lack of new COVID-19 vaccine orders from the European Union. The company said it now expects total sales between $3 billion and $3.5 billion for the year. That's down from the $4 billion forecast in the first quarter. ...

Why did Moderna stock plunge?

On Thursday, Moderna Inc (NASDAQ: MRNA) stock plunged as the company lowered its 2024 sales guidance due to weaker demand for its COVID-19 vaccines. ...

Why did Moderna stock fall 21%?

Photo: POOL/AFP via Getty Images Moderna Inc.’s stock tumbled 21% Thursday, after the biotech company cut its sales guidance for 2024, offsetting a narrower-than-expected second-quarter loss and revenue that topped estimates. It was the stock’s biggest-ever one-day decline and has erased all of its gains for the year to date. Already a subscriber? ...

Why did Moderna (mRNA) stock plunge?

On Thursday, Moderna Inc (NASDAQ:MRNA) stock plunged as the company lowered its 2024 sales guidance due to weaker demand for its COVID-19 vaccines. ...

Why did Moderna's stock tumble 21% Thursday?

Moderna’s stock was slammed early Thursday after it cut its sales guidance. Photo: POOL/AFP via Getty Images Moderna Inc.’s stock tumbled 21% Thursday, after the biotech company cut its sales guidance for 2024, offsetting a narrower-than-expected second-quarter loss and revenue that topped estimates. ...

Is Moderna a good stock to buy?

From a valuation standpoint, Moderna appears attractive compared to the industry. Going by the price/sales (P/S) ratio, the company’s shares currently trade at 4.36, trailing 12-month sales value, lower than 8.21 for the industry. Estimates for Moderna’s 2024 loss per share have increased from $9.37 to $9.85 in the past 60 days. ...